24 May 2013
Keywords: kos, launches, advicor, usa, pharmaceuticals, launched, its
Article | 04 February 2002
Kos Pharmaceuticals launched its Advicor (extended-releaseniacin/lovastatin), the first Food and Drug Administration-approved dual component therapy for cholesterol modulation, on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.